University of Wisconsin-Madison Department of Pathology and Laboratory Medicine Graphic
Photo of Andreas Friedl, MD



Department Affiliations


 
Andreas Friedl, MD
Professor
Department of Pathology and Laboratory Medicine
Email: afriedl@wisc.edu
Office: 6051 WIMR
Phone: 608.265.9283
FAX: 608.265.6215
Pager: 608.265.7000 #6009
Mailing Address:
6051 WIMR
1111 Highland Ave
Madison, WI 53705
Research Summary
Heparan sulfate proteoglycans; tumor angiogenesis
Education
1993-1995 Postdoctoral Fellowship, University of Wisconsin, Madison, WI
1989-1993 Residency in Anatomic and Clinical Pathology, University of Wisconsin, Madison, WI
1987 Dr. of Medicine (Dr. med.), University of Erlangen, Germany
1985 MD, University of Erlangen, Germany
Selected Publications
Maeda T, Alexander CM, Friedl A. Induction of syndecan-1 expression in stromal fibroblasts promotes proliferation of human breast cancer cells. Cancer Res 64 (2):612-621, 2004.
Thomas, J. P., Arzoomanian, R. Z., Alberti, D., Marnocha, R., Lee, F., Friedl, A., Tutsch, K., Dresen, A., Geiger, P., Pluda, J., Fogler, W., Schiller, J. H., and Wilding, G. Phase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors. J Clin Oncol, 21: 223-231., 2003.
Qiao, D., Meyer, K., Mundhenke, C., Drew, S. A., and Friedl, A. Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 signaling in brain endothelial cells. Specific role for glypican-1 in glioma angiogenesis. J Biol Chem, 278: 16045-16053., 2003.
Clinical Interests
• General Surgical Pathology.
• Medical diseases of the kidney.
• Breast cancer pathology.
• Immunohistochemistry and other in situ techniques.